+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nephrology And Urology Devices - Global Strategic Business Report

  • PDF Icon

    Report

  • 194 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140629
The global market for Nephrology And Urology Devices was estimated at US$26.3 Billion in 2023 and is projected to reach US$39.3 Billion by 2030, growing at a CAGR of 5.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

What Are Nephrology and Urology Devices, and Why Are They So Crucial in Modern Healthcare?

Nephrology and urology devices encompass a broad range of medical equipment designed to diagnose, treat, and manage conditions affecting the kidneys, urinary tract, bladder, and associated organs. These devices are used to address a variety of disorders, including chronic kidney disease, urinary incontinence, kidney stones, benign prostatic hyperplasia, and cancers of the urinary system. Examples include dialysis machines, catheters, ureteroscopes, lithotripters, urinary stents, and nephrostomy devices, among others. These devices play a crucial role in improving patient outcomes, providing minimally invasive treatment options, and supporting long-term management of both acute and chronic conditions.

The importance of nephrology and urology devices lies in their ability to enhance the quality of life for patients by enabling effective disease management, faster recovery, and less invasive procedures. For patients with chronic kidney disease or end-stage renal disease, dialysis machines are essential for maintaining kidney function and prolonging life. In cases of urological disorders, devices like stents, catheters, and laser systems allow for effective management of obstructions, infections, and other complications. As the prevalence of kidney-related and urological conditions continues to rise globally - due to aging populations, lifestyle factors, and comorbidities like diabetes and hypertension - these devices have become vital components of modern healthcare delivery.

How Are Technological Advancements Shaping the Nephrology and Urology Devices Market?

Technological advancements have significantly enhanced the precision, efficiency, and patient outcomes associated with nephrology and urology devices, driving innovation across the healthcare sector. One of the major developments is the rise of minimally invasive technologies, which have transformed surgical and therapeutic interventions in both nephrology and urology. Devices such as flexible ureteroscopes, laser lithotripters, and robotic-assisted systems allow for precise treatment of kidney stones, tumors, and other obstructions with reduced recovery times, minimal complications, and lower healthcare costs. Robotic surgery, for instance, enables enhanced visualization, better control, and smaller incisions, making it particularly effective in procedures like prostatectomy and partial nephrectomy.

Advancements in dialysis technology have improved the treatment of chronic kidney disease and end-stage renal disease. Modern dialysis machines feature improved filtration systems, better monitoring capabilities, and more user-friendly interfaces, making treatments safer, more efficient, and less burdensome for patients. The development of portable and wearable dialysis devices has further expanded the options for home-based care, allowing patients greater mobility and flexibility in managing their condition. Additionally, ongoing research into implantable artificial kidneys holds the potential to revolutionize renal replacement therapy, offering more permanent and less restrictive solutions for kidney failure patients.

The development of digital health tools and remote monitoring solutions has also enhanced the management of nephrology and urology conditions. Telemedicine, wearable sensors, and mobile health apps are now used to track patient health metrics, such as fluid levels, blood pressure, and urine output, providing healthcare professionals with real-time data to optimize treatment plans. For example, continuous monitoring of patients undergoing dialysis or treatment for urinary retention can help detect complications early, enabling timely interventions and reducing hospital readmissions. These technological innovations not only expand the capabilities of nephrology and urology devices but also align with broader trends toward personalized, data-driven, and patient-centric care in modern healthcare.

What Are the Emerging Applications of Nephrology and Urology Devices Across Different Patient Groups?

Nephrology and urology devices are finding expanding applications across diverse patient groups, driven by increasing prevalence of kidney and urological disorders and the need for more effective, less invasive treatment options. In the treatment of kidney stones, for example, ureteroscopes, lithotripters, and stents are widely used to facilitate stone removal or fragmentation. These devices are commonly employed across adult and pediatric populations, offering effective solutions for acute management and long-term prevention of recurrence. The use of extracorporeal shock wave lithotripsy (ESWL), which breaks down stones non-invasively, has become a preferred treatment method due to its minimal complications and faster recovery times.

For patients with chronic kidney disease or end-stage renal disease, dialysis machines are essential for maintaining kidney function. Hemodialysis and peritoneal dialysis devices serve different patient needs, with hemodialysis being more common in clinical settings and peritoneal dialysis offering greater flexibility for home-based care. Recent advancements have focused on improving patient comfort, reducing treatment duration, and enhancing efficiency. Portable dialysis machines, for instance, allow patients to receive dialysis at home or while traveling, providing more autonomy and a better quality of life.

In the management of benign prostatic hyperplasia (BPH), devices like prostatic stents, transurethral resection of the prostate (TURP) equipment, and laser systems have become standard treatment options, particularly among older male patients. These devices provide effective relief from urinary obstruction and improve urine flow, offering minimally invasive solutions with shorter hospital stays and reduced risks of complications. In addition, urinary incontinence devices, such as catheters, slings, and sacral neuromodulation implants, offer targeted solutions for different types of incontinence, addressing the needs of both male and female patients across a wide age range.

In cancer treatment, nephrology and urology devices are used for biopsy, tumor ablation, and surgical interventions. Devices like laparoscopic nephrectomy tools, cystoscopes, and laser ablation systems allow for precise removal or treatment of cancerous tissues while preserving healthy structures. The use of advanced imaging technologies in conjunction with these devices has improved early detection, diagnosis, and targeted treatment of cancers like renal cell carcinoma and bladder cancer. The expanding applications of nephrology and urology devices across these patient groups highlight their critical role in enhancing patient outcomes, improving quality of life, and supporting comprehensive care for kidney and urological disorders.

What Drives Growth in the Nephrology and Urology Devices Market?

The growth in the nephrology and urology devices market is driven by several factors, including increasing prevalence of kidney and urological disorders, rising demand for minimally invasive treatments, and advancements in medical technology. One of the primary growth drivers is the global rise in chronic kidney disease and end-stage renal disease, largely due to aging populations, lifestyle changes, and higher rates of diabetes and hypertension. As more patients require long-term management and renal replacement therapy, the demand for dialysis machines, catheters, and other related devices has increased, supporting market expansion.

The growing preference for minimally invasive surgical techniques has also fueled demand for advanced urology devices. Patients and healthcare providers are increasingly opting for treatments that offer quicker recovery, reduced pain, and fewer complications. Minimally invasive technologies, such as laser lithotripsy for kidney stones and robotic-assisted surgery for prostate and kidney tumors, have become popular choices, driving demand for ureteroscopes, lasers, and robotic systems. This shift toward less invasive interventions has supported the adoption of innovative devices that offer better precision, safety, and effectiveness in treating kidney and urological disorders.

Advancements in medical technology, including digital health tools and portable devices, have contributed to market growth by improving access to care and patient outcomes. Innovations like wearable sensors, remote monitoring devices, and mobile health applications allow for continuous monitoring of patients with chronic conditions, supporting better disease management and timely interventions. For instance, home-based dialysis machines enable more patients to receive treatment outside traditional clinical settings, enhancing convenience and reducing healthcare costs. These advancements align with broader healthcare trends toward personalized, patient-centric care and integrated digital solutions.

Government initiatives and healthcare infrastructure development have also played a key role in driving the nephrology and urology devices market. Increased healthcare spending, improved insurance coverage, and public awareness campaigns about kidney and urological health have boosted the adoption of medical devices in both developed and developing regions. Regulatory support for new device approvals and reimbursement policies has further facilitated access to advanced treatment options, ensuring broader availability of nephrology and urology devices in global markets.

With ongoing innovations in medical devices, telehealth, and minimally invasive techniques, the nephrology and urology devices market is poised for continued growth. These trends, combined with increasing demand for effective disease management, improved patient outcomes, and advanced treatment options, make nephrology and urology devices vital components of modern healthcare strategies across diverse patient populations.

Scope of the Study

The report analyzes the Nephrology And Urology Devices market, presented in terms of market value (US$ Million). The analysis covers the key segments and geographic regions outlined below.

Segments

Type (Dialysis Devices, Endoscopy Devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices, Other Types)

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Dialysis Devices segment, which is expected to reach US$28.9 Billion by 2030 with a CAGR of a 6.2%. The Endoscopy Devices segment is also set to grow at 5.4% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $7.0 Billion in 2023, and China, forecasted to grow at an impressive 8.9% CAGR to reach $9.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Nephrology And Urology Devices Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Nephrology And Urology Devices Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Nephrology And Urology Devices Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Global Nephrology And Urology Devices Market such as Asahi Kasei Corp, B. Braun Group, Boston Scientific Corporation, Siemens Healthineers, Cardinal Health Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 41 companies featured in this Global Nephrology And Urology Devices Market report include:

  • Asahi Kasei Corp
  • B. Braun Group
  • Boston Scientific Corporation
  • Siemens Healthineers
  • Cardinal Health Inc.
  • Cook Group Incorporated
  • Dornier Medtech
  • Medtronic plc
  • Olympus Europa SE & Co. KG
  • Teleflex Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Nephrology And Urology Devices - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Kidney Disorders Drives Demand for Nephrology Devices
  • Expanding Geriatric Population Sets the Stage for Urology Device Adoption
  • Growing Focus on Minimally Invasive Surgeries Propels Device Demand
  • Advancements in Dialysis Technology Strengthen Business Case for Nephrology Devices
  • Increasing Use of Catheters in Urology Drives Market Growth
  • Use in Robotic-assisted Urological Surgeries Expands Addressable Market
  • Growing Applications in Prostate Treatment Enhance Demand for Devices
  • Rising Focus on Home-based Dialysis Sets the Stage for Nephrology Device Growth
  • Increasing Demand for Incontinence Management Drives Urology Device Market
  • Advancements in Stents Propel Demand for Nephrology and Urology Devices
  • Strategic Focus on Telehealth Solutions Generates Opportunities
  • Increasing Use of Nephrostomy Devices Generates Demand
  • Strong Growth in Ambulatory Surgical Centers Drives Nephrology Device Demand
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Nephrology And Urology Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Nephrology And Urology Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Nephrology And Urology Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Dialysis Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Dialysis Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Dialysis Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Endoscopy devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Endoscopy devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Endoscopy devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Benign Prostatic Hyperplasia (BPH) Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Urinary Stone Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for Urinary Stone Treatment Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for Urinary Stone Treatment Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 24: USA Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: USA 16-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2014, 2024 & 2030
CANADA
  • Table 26: Canada Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: Canada Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: Canada 16-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2014, 2024 & 2030
JAPAN
  • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 29: Japan Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: Japan Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: Japan 16-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2014, 2024 & 2030
CHINA
  • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 32: China Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: China Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: China 16-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2014, 2024 & 2030
EUROPE
  • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 35: Europe Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 36: Europe Historic Review for Nephrology And Urology Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: Europe 16-Year Perspective for Nephrology And Urology Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 38: Europe Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: Europe Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: Europe 16-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2014, 2024 & 2030
FRANCE
  • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 41: France Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: France Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: France 16-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2014, 2024 & 2030
GERMANY
  • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 44: Germany Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: Germany Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: Germany 16-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2014, 2024 & 2030
ITALY
  • Table 47: Italy Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 48: Italy Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: Italy 16-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 50: UK Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: UK Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: UK 16-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2014, 2024 & 2030
SPAIN
  • Table 53: Spain Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: Spain Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: Spain 16-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2014, 2024 & 2030
RUSSIA
  • Table 56: Russia Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: Russia Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: Russia 16-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 59: Rest of Europe Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: Rest of Europe Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: Rest of Europe 16-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 62: Asia-Pacific Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 63: Asia-Pacific Historic Review for Nephrology And Urology Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: Asia-Pacific 16-Year Perspective for Nephrology And Urology Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 65: Asia-Pacific Recent Past, Current & Future Analysis for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 66: Asia-Pacific Historic Review for Nephrology And Urology Devices by Type - Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Asia-Pacific 16-Year Perspective for Nephrology And Urology Devices by Type - Percentage Breakdown of Value Sales for Dialysis Devices, Endoscopy devices, Benign Prostatic Hyperplasia (BPH) Treatment Devices, Urinary Incontinence and Pelvic Organ Prolapse Treatment Devices, Urinary Stone Treatment Devices and Other Types for the Years 2014, 2024 & 2030
AUSTRALIA
  • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Nephrology And Urology Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned

  • Asahi Kasei Corp
  • B. Braun Group
  • Boston Scientific Corporation
  • Siemens Healthineers
  • Cardinal Health Inc.
  • Cook Group Incorporated
  • Dornier Medtech
  • Medtronic plc
  • Olympus Europa SE & Co. KG
  • Teleflex Inc.

Table Information